TFF Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Austin, TX
SEC filing record 1 source field available
Fiscal year end
31 December
TFF Pharmaceuticals, Inc. has filed 317 SEC EDGAR filings since 27 Mar 2018

SEC filing history

Showing 126-150 of 317 matching filings.

Per page
25
Current page
6
8-K File 001-39102

CURRENT REPORT

Filing date
08 Mar 2023
Reporting date
02 Mar 2023
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
07 Mar 2023
Reporting date
07 Mar 2023
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
17 Feb 2023
Reporting date
16 Feb 2023
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
16 Feb 2023
Reporting date
16 Feb 2023
Next action
Verify source filing
SC 13G/A File 005-91311

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91311

SC 13G/A filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
09 Feb 2023
Reporting date
08 Feb 2023
Next action
Verify source filing
SC 13G/A File 005-91311

SC 13G/A

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
20 Jan 2023
Reporting date
05 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
11 Jan 2023
Reporting date
05 Jan 2023
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Dec 2022
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Dec 2022
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Dec 2022
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Dec 2022
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39102

DEFINITIVE PROXY STATEMENT

Filing date
27 Dec 2022
Reporting date
08 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39102

PRELIMINARY PROXY STATEMENT

Filing date
15 Dec 2022
Reporting date
08 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
08 Dec 2022
Reporting date
04 Dec 2022
Next action
Verify source filing
4

4 filing

Filing date
06 Dec 2022
Reporting date
03 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91311

SC 13G

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91311

SC 13G filing

Filing date
23 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Nov 2022
Reporting date
22 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
18 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39102

CURRENT REPORT

Filing date
18 Nov 2022
Reporting date
17 Nov 2022
Next action
Verify source filing
424B5 File 333-249870

PROSPECTUS SUPPLEMENT

Filing date
17 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .